Less Ads, More Data, More Tools Register for FREE

Pin to quick picksThg Regulatory News (THG)

Share Price Information for Thg (THG)

Share Price is delayed by 15 minutes
Get Live Data
33.36    0.36 (1.09%)
Bid:
33.16
Ask:
33.42
Spread: 0.26 (0.784%)
Market Cap: £529.37m
THG Live PriceLast checked at - London Stock Exchange

Intraday Thg Share Chart

Q4 Trading Statement

18 Jan 2022 07:00

RNS Number : 7443Y
THG PLC
18 January 2022
Β 

18 January 2022

Β 

THG PLC

Β 

Fourth quarter trading statement for the period ended 31 December 2021

Β 

Β 

Q4 2021 Group revenue of Β£711.7m, +29.7%1Β YoY and +95.7% 2 year growth

Β 

FY 2021 revenue of Β£2.2bn, +37.9%1 YoY and +95.0% 2 year growth

Β 

Strong revenue growth expected for FY 2022; +22.0% to +25.0% YoY, including Β£108.0m - Β£112.0m for Ingenuity Commerce

Β 

Β 

Β 

THG PLC ("THG" or the "Group"), the global proprietary technology platform specialising in taking brands direct to consumers ("D2C"), announces a trading update for the period ended 31 December 2021 ("Fourth Quarter" or "Q4 2021").

Β 

Q4 & FY 2021 Group Trading Performance

Β£m

Q4 2021

Q4 2020

YoY2

Growth

YoY

Growth

CCY

2 Year

Growth

2 Year

Growth

CCY

Β 

Β 

Β 

Β 

Β 

Β 

Β 

THG Beauty

407.9

298.5

36.7%

38.9%

127.4%

130.4%

THG Nutrition

171.8

158.9

8.1%

12.1%

51.6%

55.6%

THG OnDemand

46.5

41.9

10.9%

13.1%

101.1%

101.7%

THG Ingenuity

57.4

40.5

41.8%

42.7%

65.4%

70.7%

Other

28.0

20.0

39.7%

37.6%

44.6%

42.1%

Group Revenue

711.7

559.8

27.1%

29.7%

92.4%

95.7%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Ingenuity Commerce Revenue

15.4

7.3

111.1%

111.1%

415.0%

415.0%

Annual Revenue Run-Rate (ARR)

61

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Β£m

FY 2021

FY 2020

YoY

Growth

YoY

Growth

CCY

2 Year

Growth

2 Year

Growth

CCY

Β 

Β 

Β 

Β 

Β 

Β 

Β 

THG Beauty

1,116.3

751.6

48.5%

51.4%

133.4%

137.8%

THG Nutrition

659.5

562.3

17.3%

20.8%

59.7%

63.3%

THG OnDemand

128.1

101.3

26.5%

29.4%

119.3%

122.1%

THG Ingenuity

194.3

137.3

41.4%

43.4%

51.8%

56.5%

Other

80.2

61.1

31.3%

28.0%

28.0%

25.5%

Group Revenue

2,178.3

1,613.6

35.0%

37.9%

91.1%

95.0%

Β 

Β 

Β 

Β 

Β 

Β 

Β 

Ingenuity Commerce Revenue

45.4

19.3

135.2%

135.2%

512.3%

512.3%

Β 

1Β Any reference to revenue growth throughout this document is on a constant currency basis (β€œCCY”). Removing fluctuations arising from translation of foreign exchange by restating prior year numbers at current year exchange rates.

2Β YoY defined as year-on-year statutory sales growth.

Β 

Β 

Matthew Moulding, CEO commented:

"We are delighted to report significant growth across all divisions during the peak Q4 trading period and to have delivered record annual sales of Β£2.2billion.

Β 

"The operational resilience and performance of our Ingenuity infrastructure was a highlight, dispatching over one million units per day at peak periods. The investment we have made in automation in the UK delivered year-on-year efficiencies, and we are on track to launch our first AutoStore facility in the US during Q2 2022, supplementing the six warehouses added to the network across three continents during 2021.

Β 

"2021 marked our first full year as a public company and I would like to express my gratitude to all THG colleagues for their dedication and hard work in helping us achieve such a strong performance for the year. Despite challenging conditions, we have scaled revenue and expanded our business model, particularly THG Ingenuity, well ahead of expectations given at our IPO 16 months ago. At the same time, we welcomed c.3,000 new employees across the world to the Group, the majority of whom are within the U.K., and completed many transformational projects, including the opening of our 1m sq. ft. U.K. technology campus, ICON.

Β 

"During the year, the Group also invested around one billion pounds across infrastructure, technology and M&A to further develop the long-term growth prospects of our key trading divisions. We remain committed to our strategy of investing for growth across our global fulfilment network and technology platform.

Β 

"The new year has started well, and we remain confident in delivering our strategic growth plans during 2022 and beyond."

Β 

Β 

Outlook and guidance

Momentum coming into 2022 remains strong across the Group following an acceleration in organic revenue growth in Q4 vs. Q3 2021 and with a substantial pipeline of site launches within THG Ingenuity. While the early part of 2022 is expected to be a more challenging comparable period due to global lockdowns in H1 2021, and record commodity prices within our Nutrition division, the Board expects FY 2022 revenue growth of +22.0% to +25.0% (CCY).

Β 

FY 2021 adjusted EBITDA margin is expected to be in the range of 7.4% to 7.7%, compared to market expectations of c.7.9%, after taking into account c.90bps of adverse foreign currency movements.

Β 

For FY 2022, the Group expects adjusted EBITDA margins to improve throughout the year as we see the benefits of 2021 investments in automation offsetting inflationary pressures, in addition to the increasing mix of revenues generated from Ingenuity Commerce. The phasing is expected to be weighted to the second half of the year, given movements in raw material prices, transport costs and currencies.

Β 

Q4 & FY 2021 highlights

Β· Q4 2021 revenue growth of +29.7%, with accelerated momentum in organic sales during peak underpinning a full year revenue increase of +37.9%.

Β· THG Beauty delivered sales growth of +38.9%, with six orders per second placed during the peak cyber period. Post platform migration, meaningful customer service improvements were realised including a 0.8 day average reduction in delivery service in the US for Dermstore, and an extended seven hour next day delivery cut-off time for Cult Beauty UK customers due to THG Ingenuity's expansive courier relationships.

Β· THG Nutrition delivered revenue of Β£171.8m, +12.1% YoY, with FY 2021 sales +20.8% vs FY 2020. Growth was broad based with the UK and US delivering growth of +70% on a 2 year basis, with a call out performance in Japan for Singles Day.

Β· Enhanced consumer order value and frequency metrics across app users with 6.8m app downloads since 2020 launch (FY 2021: 4.2m), now accounting for c.7% of D2C Group sales3.

Β· Influencers continued to play an important role in marketing, generating c.23% of Nutrition Cyber month sales (November 2021) and c.11% of total Group D2C revenue for FY 2021 on a tracked4Β basis (vs 9% in FY 2020).

Β· Demand in our large consumer and technology markets remains strong and we continue to win customers at expected levels, with +89% growth in new D2C customers to the Group in 2021 vs. 2019. New and existing customer behaviour metrics remain consistent with the pre-pandemic environment; notably, revenue from returning Lookfantastic and Myprotein customers represented c.80% of sales in FY 2021, with stable average order values.

Β· Total cash of over Β£530m at year end plus an undrawn facility of Β£170m, on long dated 3-5 year terms.

Β 

Ingenuity Commerce update

Β· FY 2021 revenue growth of 135.2% to Β£45.4m, with material new client wins in late Q4 contributing from Q1 2022 onwards, supporting our re-iteration of FY 2022 revenue guidance of Β£108.0m - Β£112.0m.

Β· Site number growth during the year was driven by enterprise-scale corporates across a diverse range of categories with over 75% of live sites in major international territories (UK, US, France, Germany, China, Japan and Australia).

Β· Average recurring revenue per website in Q4 2021 increased to Β£0.24m reflecting the increase in Gross Merchandise Value processed during the peak quarter.

Β 

3Β Excluding Dermstore and Cult Beauty.

4 Tracked is based on revenues via link last click attribution and codes which may have a last click attribution of other digital channels.

Β 

Β 

Β 

Q4

2021

Q3

2021

Q2

2021

Number of live client websites5

187

163

133

Average recurring revenue per website6Β (Β£m)

0.24

0.17

0.17

Recurring Revenue %7

72%

59%

55%

Annual Revenue Run-Rate8Β (Β£m)

61

44

37

Β 

5Β Number of websites defined as website with a specific domain name/URL live at the end of the period.

6Β Average recurring revenue per website is presented on an annual basis.

7Β Based on total Ingenuity Commerce revenue.

8Β Annual Revenue Run-rate is based on annualised recurring revenue and trailing 12 months non-recurring revenue.

Β 

Β 

Β 

Analyst and investor conference call

Β 

THG will today host a conference call and webcast for analysts and investors at 9.00am (UK time) via the following links:

Β 

To register for the webcast, please use the below link:

https://brrmedia.news/THG_Q421Β 

Β 

To ask questions, you must dial in via conference line using the below details:

Β· Room number: 7571352

Β· UK dial in: +44 (0)330 336 9601

Β 

Β 

For further information please contact:Β 

Β 

Investor enquiries:

Β 

Kate Grimoldby, Head of Investor Relations

Investor.Relations@thg.com

Β 

Media enquiries:

Β 

Powerscourt - Financial PR adviser

Tel: +44 (0) 20 7250 1446

Victoria Palmer-Moore/Nick Dibden/Nick Hayns

thg@powerscourt-group.com

Β 

THG PLC

Viki Tahmasebi

Β 

Β 

Β 

Viki.tahmasebi@thg.com

Β 

Β 

Β 

ENDS

Notes to editors

THG (www.thg.com) is a vertically integrated, global, digital-first consumer brands group, retailing its own beauty and nutrition brands, plus leading third-party brands, via its proprietary, end-to-end, e-commerce technology, infrastructure and brand-building platform (THG Ingenuity). THG's business is operated through the following businesses:

THG Ingenuity: Ingenuity Commerce provides end-to-end technology services charged to third party clients for digital commerce solutions. Ingenuity Infrastructure underpins the Ingenuity Commerce offering, and is charged to third parties as a single stand-alone service. Services include hosting, content creation through THG Studios, translation services and beauty product development and manufacturing.

THG Beauty: The globally pre-eminent digital-first brand owner, retailer and manufacturer in the prestige beauty market, combining its portfolio ofΒ eightΒ owned brands across skincare, haircare and cosmetics, the provision of a global route to market for over 1,000 third-party beauty brands through its portfolio of websites, including Lookfantastic, Dermstore, Cult Beauty and Mankind and the beauty subscription box brand GLOSSYBOX.

Β 

THG Nutrition:Β A group of digital-first Nutrition brands, which includesΒ the world's largestΒ onlineΒ sports nutrition brand Myprotein,Β andΒ its family of brandsΒ (Myvegan, Myvitamins,Β MP Clothing and Myprotein Pro),Β with a vertically integrated business model, supported byΒ sixΒ THG production facilities.

Β 

THG OnDemand: Personalisation and customisation services to major brands and global publishing houses, typically under licensing agreements, enabling brands to offer unique products to consumers through websites including Zavvi, IWOOT and Pop in a Box.

Other: Luxury D2C websites including Coggles, AllSole and MyBag, as well as THG Experience, which comprises prestige locations at Hale Country Club & Spa, King Street Townhouse Hotel and Great John Street Hotel, providing deeply experiential brand building environments, most notably in support of THG Society, the Group's proprietary influencer marketing platform.

Β 

Β 

Cautionary Statement

This announcement may include "forward-looking statements" in respect of the Group's operations, performance, prospects and/or financial condition. Forward-looking statements are sometimes, but not always, identified by their use of a date in the future or such words and words of similar meaning as "anticipates", "aims", "due", "could", "may", "will", "should", "expects", "believes", "intends", "plans", "potential", "targets", "goal" or "estimates". By their nature, forward-looking statements involve a number of risks, uncertainties and assumptions and actual results or events may differ materially from those expressed or implied by those statements. Factors which may cause future outcomes to differ from those foreseen in forward-looking statements include, but are not limited to, those identified in the "Risk Management" section of the Group's 2020 Annual Report. Accordingly, no assurance can be given that any particular expectation will be met and reliance should not be placed on any forward-looking statement. Additionally, forward looking statements regarding past trends or activities should not be taken as a representation that such trends or activities will continue in the future.

Except as required by any law or regulation, no responsibility or obligation is accepted to update or revise any forward-looking statement resulting from new information, future events or otherwise. Past performance cannot be relied upon as a guide to future performance and persons needing advice should consult an independent financial adviser. Nothing in this announcement should be construed as a profit forecast.

This announcement does not constitute or form part of any offer or invitation to sell, or any solicitation of any offer to purchase any shares or other securities in the Group nor shall it or any part of it or the fact of its distribution form the basis of, or be relied on in connection with, any contract or commitment or investment decisions relating thereto, nor does it constitute a recommendation regarding the shares or other securities of the Group. Statements in this announcement reflect the knowledge and information available at the time of its preparation.

Β 

Β 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
Β 
END
Β 
Β 
TSTGPUMUGUPPPWM
Date   Source Headline
22nd May 20267:00 amRNSNotice of AGM
21st Apr 20267:00 amRNSTrading Statement
20th Apr 20264:45 pmRNSNotice of Q1 Trading Update
8th Apr 20267:00 amRNSAnnual Report & Accounts 2025
26th Mar 20267:00 amRNSPreliminary FY 2025 results
25th Mar 20264:54 pmRNSNotice of Results
24th Feb 20267:45 amRNSPDMR/PCA Shareholding & TR-1 Notification
12th Feb 20267:00 amRNS-RMyprotein licensing partnership with Greencore
2nd Feb 20267:00 amRNSTotal Voting Rights
27th Jan 20263:49 pmRNSTR-1: Notification of major holdings
27th Jan 20263:45 pmRNSTR-1: Notification of Major Holdings
23rd Jan 20262:52 pmRNSTR-1: Notification of Major Holdings
22nd Jan 20263:00 pmRNSApplication for Listing and Total Voting Rights
16th Jan 20267:00 amRNSChange to Board Committee Membership
13th Jan 20267:00 amRNSQ4 2025 Trading Statement
12th Jan 20264:40 pmRNSNotice of Results
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
19th Dec 20252:20 pmRNSTR-1: Notification of Major Holdings
16th Dec 20255:50 pmRNSTR-1: Notification of Major Holdings
9th Dec 20254:35 pmRNSTR-1: Notification of Major Holdings
9th Dec 202510:55 amRNSTR-1: Notification of Major Holdings
9th Dec 20259:15 amRNSPDMR/PCA Shareholding & TR-1 Notification
5th Dec 202510:15 amRNSDirector Declaration
5th Dec 202510:05 amRNSAdmission of Convertible Loan Shares and TVR
26th Nov 20259:45 amRNSPDMR/PCA Shareholdings
17th Nov 20257:00 amRNS-RMyprotein joins forces with Mars
3rd Nov 20257:00 amRNSBlock listing Interim Review
28th Oct 202511:14 amRNSDirector Declaration
14th Oct 20257:00 amRNSQ3 2025 Trading Statement
10th Oct 20257:00 amRNSNotice of Trading Update
19th Sep 20256:00 pmRNSOcean Wilsons
11th Sep 20257:00 amRNSInterim results for half-year ended 30 June 2025
10th Sep 20254:45 pmRNSNotice of Interim Results
5th Sep 20257:00 amRNSNotification under UKLR 6.4.9R(2)
6th Aug 20257:42 amRNSDisposal, H1 trading and Nutrition update - Amend
6th Aug 20257:00 amRNSDisposal, H1 trading and Nutrition update
9th Jul 20252:24 pmRNSChanges to Directors’ Responsibilities
25th Jun 20252:38 pmRNSResult of AGM
25th Jun 20257:00 amRNSAGM Trading Statement
5th Jun 20253:56 pmRNSTR-1: Notification of Major Holdings
23rd May 20257:00 amRNSNotice of AGM
1st May 20257:00 amRNSBlock Listing Six Monthly Return
30th Apr 20257:00 amRNSAnnual Report & Accounts 2024
29th Apr 20257:00 amRNSFY 2024 results and Q1 trading statement
23rd Apr 20257:00 amRNSResponse to media speculation
16th Apr 20254:45 pmRNSTR-1: Notification of Major Holdings
4th Apr 202510:30 amRNSTR-1: Notification of Major Holdings
4th Apr 20257:00 amRNSCompletion of debt refinancing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.